TÜBINGEN, Germany / BOSTON, MA, USA – November 21, 2018

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 19th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 27, 2018 at 10:50 a.m. ET.

A live audio broadcast of the presentation will be available at www.curevac.com/en/newsroom/curevacevents. An archived replay of the presentation will be available on the company’s website for 3 months following the presentation.

CureVac N.V.
Tübingen, GermanyFriedrich-Miescher-Str. 1572076 TübingenT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac AG
Tübingen, GermanyHeadquartersFriedrich-Miescher-Str. 1572076 TübingenT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac AG
Frankfurt, GermanyClinical developmentSchumannstr. 2760325 FrankfurtT +49 69 7680 587 - 0F +49 69 7680 587 - 2222
CureVac Real Estate GmbH
Tübingen, GermanyFriedrich-Miescher-Str. 1572076 TübingenT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac Corporate Services GmbH
Tübingen, GermanyFriedrich-Miescher-Str. 1572076 TübingenT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac Inc.
Boston, USA250 Summer St 3rd FlBoston, MA 02210, USAP +1 617 377404 - 0
CureVac Swiss AG
Basel, SwitzerlandWartenbergstraße 40CH-4052 BaselT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac RNA Printer GmbH
Tübingen, GermanyFriedrich-Miescher-Str. 1572076 TübingenT +49 7071 9883 - 0F +49 7071 9883 - 1101
CureVac Belgium SA
Ottignies-Louvain-la-Neuve, BelgiumAv. Jean Monnet 41348 Ottignies-Louvain-la-Neuve
Social